Journal of Human Reproductive Sciences, 2009 Aims: To study the prevalence of clinical manifestations in obese and lean polycystic ovarian syndrome (PCOS) women and their health hazards. Settings and Design: This prospective study was carried out in a tertiary care infertility clinic from 1.7.2005
Abha Majumdar, Tejshree A Singh
doaj +1 more source
Clinical profile of PCOS patients at a tertiary care center in Gandaki Province of Nepal
Asian Journal of Medical Sciences, 2020 Background: Polycystic Ovary Syndrome is one of the most common cause of anovulation in women of reproductive age, with a prevalence of upto 10%. Oligomenorrhea, hirsutism and obesity together with enlarged polycystic ovaries are the diagnostic criteria ...
Mahendra Raj Pandey
doaj +1 more source
Oxygen Hyperbaric Exposure Induces GLUT4 Expression Reduction and No Folliculogenesis Alterations in Rat PCOS with Insulin Resistance Model [PDF]
, 2015 Objectives: To know effect of hyperbaric oxygen therapy to GLUT4 expression and folliculogenesis in rat PCOS with insulin resistent model.Materials and Methods: this is an analytic experimental study used 30 rats induced by testosterone propionate ...
Santoso, B. (Budi) +2 more
core +2 more sources
Journal of Education, Health and Sport, 2021 Introduction. In women with polycystic ovary syndrome, infertility is a serious and urgent problem, which is caused not only by anovulatory menstrual cycles [1], but also by changes in the histological structure of the endometrium, which adversely ...
A. Khmil Doswald, L. Malanchuk
doaj +1 more source
Does Metformin combined with Clomiphene Citrate improve fertility related outcomes in Clomiphene resistant women with PCOS : a systematic review [PDF]
, 2014 Peer reviewedPublisher ...
Colleran, Rebecca +5 more
core +2 more sources
Polycystic ovary syndrome: individualized approach to treatment. Literature review
Репродуктивная эндокринология, 2020 Polycystic ovary syndrome (PCOS) is one of the most common causes of hyperandrogenism, menstrual irregularity and cardiometabolic dysfunction in women.
Л. А. Жабіцька
doaj +1 more source
The Reproductive Outcome of Women with Hypogonadotropic Hypogonadism in IVF
Frontiers in Endocrinology, 2022 ObjectiveThe purpose of this study was to evaluate the reproductive outcome of patients with hypogonadotropic hypogonadism (HH) receiving in vitro fertilization and embryo transfer (IVF-ET).MethodsThe reproductive outcome of 81 HH patients and 112 ...
Chun-mei Zhang +28 more
doaj +1 more source
Optimization of ovarian function and metabolic status in syndrome of polycystic ovaries
Репродуктивная эндокринология, 2020 Objective: to evaluate the effect of the Quinofolic complex (myo-inositol 500 mg, D-chiro-inositol 12.5 mg, methyltetrahydrofolate 250 mcg) on ovarian function, metabolic status and biochemical hyperandrogenism in women with classic phenotypic phenotype ...
Т. Ф Татарчук +3 more
doaj +1 more source
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration [PDF]
, 2012 Hyperprolactinemia is the most common cause of hypogonadotropic anovulation and is one of the leading causes of infertility in women aged 25-34. Hyperprolactinemia has been proposed to block ovulation through inhibition of GnRH release.
Alain Caraty +10 more
core +4 more sources
Can Treatment for Polycystic Ovarian Disease Induce Ovarian Tumour? A Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2014 Polycystic ovarian disease in adolescents is not uncommon. Usually underlying ovarian tumours can cause hirsutism and ovulation. A 15-year-old girl presented with infrequent cycles and hirsutism.
Gowri Dorairajan +2 more
doaj +1 more source